Загрузка...
The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial
BACKGROUND/AIMS: We aim to evaluate the efficacy and safety of phloroglucinol in patients with diarrhea-predominant irritable bowel syndrome (IBS-D). METHODS: Seventy-two patients with IBS-D who met Rome III criteria were 1:1 randomized in a parallel, double-blind design to receive phloroglucinol or...
Сохранить в:
| Опубликовано в: : | J Neurogastroenterol Motil |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Society of Neurogastroenterology and Motility
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6955199/ https://ncbi.nlm.nih.gov/pubmed/31917916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm19160 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|